Compare DraftKings Inc (DKNG) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DraftKings Inc vs McKesson Corporation — how do they compare? DraftKings Inc trades at $25.15 (market cap $12.58B), while McKesson Corporation trades at $898.01 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 8.4× DraftKings Inc's market cap, and McKesson Corporation pays a 0.42% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals.
| DKNG | MCK | |
|---|---|---|
Market Cap | $12.58B | $105.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $48.23 | $995.69 |
52-Week Low | $20.72 | $659.01 |
Enterprise Value | $13.51B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
